InsiderDB
Sign inStart free trial

Cencora (COR)

Healthcare · Medical - Distribution

7 members of Congress have disclosed 18 trades in Cencora (COR) since 2021: 10 buys and 8 sales. The most recent was disclosed on Nov 5, 2026. 2 trades were made by members of a committee that oversees Cencora's industry.

Trades disclosed
18
Members trading
7
Buys / sells
10 / 8
Reported value
$271K–$815K

Keep following the company.

Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.

Follow COR

What else is happening at COR

All research →

Company filings and public records connected to this stock, ordered by when they became public or were first observed.

  1. CORCompany announcement·SEC EDGAR

    COR: Company disclosure

    Filed 8-K for an event or period dated 2026-11-04. Company disclosure.

    Public: Nov 4, 2026, 9:25 AM ESTEvent / period: Nov 4, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  2. CORCompany announcement·SEC EDGAR

    COR: Financial results · Company disclosure

    Filed 8-K for an event or period dated 2026-11-04. Financial results; Company disclosure.

    Public: Nov 4, 2026, 6:37 AM ESTEvent / period: Nov 4, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  3. CORCompany announcement·SEC EDGAR

    COR: Financial results · Company disclosure

    Filed 8-K for an event or period dated 2026-10-21. Financial results; Company disclosure.

    Public: Oct 21, 2026, 7:48 AM EDTEvent / period: Oct 21, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  4. CORLobbying report·Lobbying disclosures

    COR: third_quarter 2026 lobbying report

    Issues related to Healthcare Reform. The FY2027 Budget Resolution (H.Con.Res 113): issues related to the tax treatment of the LIFO inventory valuation method and business tax issues. The FY2027 National Defense Authorization Act (H.R.8800/S.4784): issues related to DoDs supply of essential and lifesaving medicines.

    Public: Oct 20, 2026, 11:35 PM EDTOriginal source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  5. CORLobbying report·Lobbying disclosures

    COR: third_quarter 2026 lobbying report

    Ensuring Community Access to Pharmacist Services Act (H.R. 3164)/ Main Street Pharmacy Access Act (H.R. 3164)/ Equitable Community Access to Pharmacist Services Act  (S.2426) Inflation Reduction Act implementation, including impact on Pharmacy & Physician Reimbursement Protecting Patient Access to Cancer and Complex Therapies Act 2025 (H.R 4299) Reimbursement policies impacting drug shortages Part B drug pricing changes Preventing and mitigating generic drug shortages CMS FY 2026 Medicare Part B Physician Fee Schedule Medicare physician reimbursement CY2026 Medicare Physician Fee Schedule Rule

    Public: Oct 20, 2026, 5:07 PM EDTOriginal source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

Committee overlaps

Trades by members of a committee that oversees Cencora's industry. An overlap is a fact about the trade, not evidence of wrongdoing.

Who traded COR

All trades

From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.